Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000548798 | SCV000626395 | uncertain significance | Fanconi anemia | 2023-12-18 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 359 of the SLX4 protein (p.Lys359Asn). This variant is present in population databases (rs149470704, gnomAD 0.02%). This missense change has been observed in individual(s) with breast and/or ovarian cancer (PMID: 23840564, 32546565). ClinVar contains an entry for this variant (Variation ID: 456289). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Sema4, |
RCV000548798 | SCV002529247 | uncertain significance | Fanconi anemia | 2022-02-15 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002476097 | SCV002794251 | uncertain significance | Fanconi anemia complementation group P | 2022-02-02 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV002476097 | SCV004202563 | uncertain significance | Fanconi anemia complementation group P | 2023-06-29 | criteria provided, single submitter | clinical testing |